1. 19th Society for Neuro-Oncology Annual Meeting.

    The Lancet Oncology 16(1):18 (2015) PMID 25638541

  2. Further emphasis on research in context.

    The Lancet 384(9961):2176 (2014) PMID 25625383

  3. Further emphasis on research in context.

    The Lancet 384(9961):2176 (2014) PMID 25625383

  4. Three countries-half of the global cancer burden.

    The Lancet Oncology 15(5):483 (2014) PMID 24731400

  5. Affordable cancer care: pipedream or achievable reality?

    The Lancet Oncology 15(3):257 (2014) PMID 24534291

  6. Affordable cancer care: pipedream or achievable reality?

    The Lancet Oncology 15(3):257 (2014)

  7. Conflicts of interest in editorials in high-impact journals.

    Journal of Clinical Oncology 31(34):4375 (2013) PMID 24166530

  8. MOGA 2013 Annual Scientific Meeting

    The Lancet Oncology 14(10):928 (2013)

  9. Cancer control in Latin America and the Caribbean: a bold ambition?

    The Lancet Oncology 14(5):383 (2013)

  10. Cancer control in Latin America and the Caribbean: a bold ambition?

    The Lancet Oncology 14(5):383 (2013) PMID 23628181

  11. 54th ASH Annual Meeting

    The Lancet Oncology 14(2):112 (2013)

  12. SIOP Annual Congress

    The Lancet Oncology 13(11):1082 (2012)

  13. Multidisciplinary Head and Neck Cancer Symposium

    The Lancet Oncology 13(3):232 (2012)

  14. Striking a balance between idealism and fatalism.

    The Lancet Oncology 12(10):923 (2011) PMID 21958496

  15. Striking a balance between idealism and fatalism

    The Lancet Oncology 12(10):923 (2011)

  16. Expression of concern--validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.

    The Lancet Oncology 11(9):813 (2010) PMID 20667781

  17. The Lancet Oncologyto publish more research in 2010

    The Lancet Oncology 11(1):11 (2010)

  18. Call for papers—oncology and haematology

    The Lancet Oncology 11(6):516 (2010)

  19. Expression of concern—validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

    The Lancet Oncology 11(9):813 (2010)

  20. The Lancet Oncology to publish more research in 2010.

    The Lancet Oncology 11(1):11 (2010) PMID 20129125